<document xmlns="http://cnx.rice.edu/cnxml">
  <title>Thyroid and Antithyroid Drugs</title>
  <metadata xmlns:md="http://cnx.rice.edu/mdml">
  <md:title>Thyroid Drugs and Anti-Thyroid Drugs</md:title>
  <md:content-id>m00410</md:content-id>
  <md:uuid>960b6faf-9bf1-4efe-a115-5e232be66655</md:uuid>
  </metadata>
  <content>
  <section class="learning-objectives" id="sect-00001">
  <title>Learning Outcomes</title>
  <para id="para-00001">By the end of this section, you should be able to:</para>
  <list id="list-00001">
  <item>Identify the characteristics of thyroid and antithyroid drugs used to treat thyroid disorders.</item>
  <item>Explain the indications, actions, adverse reactions, contraindications, and interactions of thyroid and antithyroid drugs used to treat thyroid disorders.</item>
  <item>Describe nursing implications of thyroid and antithyroid drugs used to treat thyroid disorders.</item>
  <item>Explain the client education related to thyroid and antithyroid drugs used to treat thyroid disorders.</item>
  </list>
  </section>
  <section id="sect-00002">
  <title>Thyroid Drugs</title>
  <para id="para-00002"><emphasis effect="bold"><term id="term-00001">Thyroid drugs</term></emphasis> are used when the thyroid is functioning incorrectly and there is a need to replace the thyroid hormone so that the body can maintain its expected function. Thyroid drugs can be synthetic thyroid hormones or animal-based thyroid hormones. These drugs act by replacing the body’s natural thyroid hormone when the levels are low or absent within the body.</para>
  <section id="sect-00003">
  <title>Levothyroxine Sodium</title>
  <para id="para-00003">Levothyroxine sodium is a synthetic thyroid hormone that is identical to T4 produced in the body. The gastrointestinal tract absorbs 40%–80% of this synthetic hormone. The drug is greater than 99% protein bound and easily distributed. It is primarily eliminated by the kidneys, with approximately 20% of T4 being excreted in the stool (Eghtedari &amp; Correa, 2022). It comes in tablet and injectable forms and is used to treat hypothyroidism and pituitary TSH suppression. Levothyroxine is contraindicated in clients with uncorrected adrenal insufficiency: because of the role of adrenal glands in regulating stress response and cortisol production, levothyroxine’s ability to increase metabolic demands and stress may overwhelm the impaired adrenal glands, causing an adrenal crisis. Stabilization of adrenal function is crucial before starting levothyroxine treatment to prevent an adrenal crisis.</para>
  <para id="para-00004">Levothyroxine sodium has a narrow therapeutic index; careful dose titration is necessary to avoid overtreatment or undertreatment. Clients should take this drug in the morning at least 30 minutes before consuming food or fluid containing caffeine such as coffee, tea, or soda. Food and caffeinated drinks can both interfere with the absorption of levothyroxine sodium.</para>
  </section>
  <section id="sect-00004">
  <title>Liothyronine Sodium</title>
  <para id="para-00005">Liothyronine sodium is a synthetic thyroid hormone mimicking T3. This hormone replacement is commonly used to treat hypothyroidism and myxedema coma. Liothyronine can be taken orally, comes in an intravenous form, and is easily absorbed and readily distributed in the body. As with levothyroxine, liothyronine is contraindicated in clients with uncorrected adrenal insufficiency. As stated above, the adrenal glands control the stress response and cortisol levels within the body. When they are impaired, they are unable to handle the increase in metabolic rate caused by the administration of liothyronine, leading to an adrenal crisis. Adverse effects of liothyronine include anxiety, blurred vision, chest discomfort, decreased bone mineral density, and decreased urine output.</para>
  <note class="safety-alert" id="note-00001">
  <title>Similarly Named Drugs</title>
  <para id="para-00006">Do not confuse <emphasis effect="italics">levothyroxine</emphasis> sodium with <emphasis effect="italics">liothyronine</emphasis> sodium. Although these drugs are in the same drug class, they require different dosing and lab monitoring.</para>
  </note>
  </section>
  <section id="sect-00005">
  <title>Desiccated Thyroid Extract</title>
  <para id="para-00007"><term class="no-emphasis" id="term-00002">Desiccated thyroid extract</term> is a thyroid hormone developed from pig glands that is often used as an over-the-counter remedy for thyroid hormone replacement. Desiccated thyroid extract has not been approved by the Food and Drug Administration (FDA) due to a complex manufacturing process leading to issues with safety, effectiveness, and quality, with inconsistent or inaccurate dosage. <link target-id="table-00001" document="m00410"/> lists common thyroid drugs and typical routes and dosing for adult clients.</para>
  <table class="vertically-tight" id="table-00001">
  <tgroup cols="2">
  <colspec colnum="1" colname="c1" colwidth="1*"/>
  <colspec colnum="2" colname="c2" colwidth="2*"/>
  <thead>
  <row>
  <entry valign="top" align="center"><span class="blue-text"><emphasis effect="bold">Drug</emphasis></span></entry>
  <entry valign="top" align="center"><span class="blue-text"><emphasis effect="bold">Routes and Dosage Ranges</emphasis></span></entry>
  </row>
</thead>
  <tbody>
  <row>
  <entry valign="top" align="center"><term class="no-emphasis" id="term-00003">Levothyroxine sodium</term> (<term class="no-emphasis" id="term-00004">Synthroid</term>, <term class="no-emphasis" id="term-00021">Levoxyl</term>)</entry>
  <entry valign="top" align="left">Individualized dosing due to a narrow therapeutic index.<newline/>
  Standard dosing starts at 1.6 mcg/kg/day orally; increase by 12.5–25 mcg orally every 4–6 weeks if needed.<newline/>
  Serum T4 levels should be used to monitor therapeutic dosing range of drug.<newline/>
  Must be titrated based on the individual’s need and to avoid the consequences of overtreatment or undertreatment.</entry>
  </row>
  <row>
  <entry valign="top" align="center"><term class="no-emphasis" id="term-00005">Liothyronine sodium</term> (<term class="no-emphasis" id="term-00006">Cytomel</term>, <term class="no-emphasis" id="term-00022">Triostat</term>)</entry>
  <entry valign="top" align="left">25 mcg orally once daily; increase by 25 mcg orally daily every 1–2 weeks if needed.<newline/>
  <emphasis effect="italics">Maintenance dose</emphasis>: 25–75 mcg once daily.<newline/>
  Serum T3 levels should be used to monitor therapeutic dosing range of drug.</entry>
  </row>
  </tbody>
  </tgroup>
  <caption><emphasis effect="bold">Drug Emphasis Table: Thyroid Drugs</emphasis> (source: https://dailymed.nlm.nih.gov/dailymed/)</caption>
  </table>
  </section>
  </section>
  <section id="sect-00006">
  <title>Adverse Effects and Contraindications</title>
  <para id="para-00008">Common adverse effects among the thyroid drug classification include cardiac effects—such as tachycardia, palpitations, and arrhythmias—weight loss, nervousness and irritability, heat intolerance, diarrhea, abdominal cramping, headaches, and sleep disturbances.</para>
  <para id="para-00009">Contraindications for thyroid drug classification include hypersensitivity to the drug or any of its components as well as any recent myocardial infarction because thyroid drugs can increase heart rate and heart contractility. Untreated adrenal insufficiency is a contraindication because impaired adrenal glands cannot handle the increased metabolic rate cause by thyroid drugs, as is hyperthyroidism since the drugs would increase thyroid hormone levels that are already elevated.</para>
  <para id="para-00010"><link target-id="table-00002" document="m00410"/> is a drug prototype table for thyroid drugs featuring levothyroxine sodium. It lists drug class, mechanism of action, adult dosage, indications, therapeutic effects, drug and food interactions, adverse effects, and contraindications.</para>
  <table class="vertically-tight" id="table-00002">
  <tgroup cols="2">
  <colspec colnum="1" colname="c1" colwidth="1*"/>
  <colspec colnum="2" colname="c2" colwidth="1*"/>
  <tbody>
  <row>
  <entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Drug Class</emphasis></span><newline/>
  Thyroid hormone<newline count="2"/><span class="blue-text"><emphasis effect="bold">Mechanism of Action</emphasis></span><newline/>
  Replaces the amount of hormone the thyroid is unable to produce, helping to restore thyroid hormone homeostasis within the body</entry>
  <entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Drug Dosage</emphasis></span><newline/>
  Individualized dosing due to a narrow therapeutic index.<newline/>
  Standard dosing starts at 1.6 mcg/kg/day orally; increase by 12.5–25 mcg orally every 4–6 weeks if needed.<newline/>
  Serum T4 levels should be used to monitor therapeutic dosing range of drug.<newline/>
  Must be titrated based on the individual’s need and to avoid the consequences of overtreatment or undertreatment.</entry>
  </row>
  <row>
  <entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Indications</emphasis></span><newline/>
  Hypothyroidism<newline/>
  Pituitary TSH suppression<newline count="2"/><span class="blue-text"><emphasis effect="bold">Therapeutic Effects</emphasis></span><newline/>
  Restores thyroid hormone levels to normal<newline/>
  Maintains thyroid hormone homeostasis</entry>
  <entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Drug Interactions</emphasis></span><newline/>
  Dopamine<newline/>
  Glucocorticoids<newline/>
  Octreotide<newline/>
  Amiodarone<newline/>
  Digitalis<newline/>
  Iodine<newline/>
  Lithium<newline/>
  Calcium<newline/>
  Iron<newline/>
  Warfarin<newline count="2"/><span class="blue-text"><emphasis effect="bold">Food Interactions</emphasis></span><newline/>
  Soy<newline/>
  Soybean flour<newline/>
  Cotton seed meal<newline/>
  Walnuts<newline/>
  Dietary fiber may bind to levothyroxine sodium and decrease its absorption</entry>
  </row>
  <row>
  <entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Adverse Effects</emphasis></span><newline/>
  Irregular heartbeat<newline/>
  Heat intolerance<newline/>
  Irregular breathing<newline/>
  Irritability<newline/>
  Nausea<newline/>
  Tremors<newline/>
  Decreased urine output</entry>
  <entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Contraindications</emphasis></span><newline/>
  Adrenal insufficiency<newline/>
  Nontoxic goiter or nodular thyroid disease<newline count="2"/>Caution:<newline/>
  Monitor closely when administering to elderly who have underlying cardiovascular disease—may precipitate thyrotoxicosis</entry>
  </row>
  </tbody>
  </tgroup>
  <caption><emphasis effect="bold">Drug Prototype Table: Levothyroxine Sodium</emphasis> (source: https://dailymed.nlm.nih.gov/dailymed/)</caption>
  </table>
  </section>
  <section id="sect-00007">
  <title>Nursing Implications</title>
  <para id="para-00011">The nurse should do the following for clients who are taking thyroid drugs:</para>
  <list list-type="bulleted" id="list-00002">
  <item>Educate the client that thyroid replacement hormone is a lifelong therapy.</item>
  <item>Assess the client’s knowledge about signs and symptoms of overtreatment and undertreatment, adverse reactions, and contraindications and clarify any gaps in knowledge.</item>
  <item>Monitor thyroid functioning of the client and report any abnormalities or symptoms of thyroid storm, such as tachycardia, cardiac dysrhythmias, fever, heart failure, flushed skin, confusion, behavioral changes, and hypotension, to the health care provider.</item>
  <item>Provide client teaching regarding the drug and when to call the health care provider. See below for client teaching guidelines.</item>
  </list>
  <note class="client-teaching" id="note-00002">
  <para id="para-00012"><emphasis effect="bold">The client taking a thyroid drug should:</emphasis></para>
  <list list-type="bulleted" id="list-00003">
  <item>Take on an empty stomach 1/2–1 hour before breakfast for better absorption.</item>
  <item>Keep a journal of their symptoms. It may take several weeks for them to notice improved symptoms.</item>
  <item>Report symptoms of irregular heartbeat, chest pain, shortness of breath, leg cramps, headache, nervousness, irritability, sleeplessness, and heat intolerance to their health care provider because these may represent an adverse reaction or toxicity to the drug.</item>
  <item>Notify the health care provider if they are pregnant or become pregnant because the dose of the drug may need to be increased during pregnancy.</item>
  <item>Store out of reach of children and away from heat, moisture, and light.</item>
  </list>
  <para id="para-00013"><emphasis effect="bold">The client taking a thyroid drug <emphasis effect="italics">should not</emphasis>:</emphasis></para>
  <list list-type="bulleted" id="list-00004">
  <item>Stop taking unless directed by their health care provider because this drug class replaces their body’s missing thyroid hormone.</item>
  <item>Take with food because it will decrease the drug’s absorption.</item>
  <item>Take within 4 hours of taking calcium and/or iron supplements, including calcium antacids, because they may impact the drug’s absorption.</item>
  </list>
  </note>
  <note class="black-box" id="note-00003">
  <para id="para-00014"><emphasis effect="bold">Thyroid Hormones</emphasis></para>
  <para id="para-00015">Thyroid hormones, including levothyroxine sodium, either alone or with other therapeutic agents, should not be used for treatment of obesity or weight loss due to producing serious toxicity or life-threatening manifestations.</para>
  </note>
  </section>
  <section id="sect-00008">
  <title>Antithyroid Drugs</title>
  <para id="para-00016"><emphasis effect="bold"><term id="term-00007">Antithyroid drugs</term></emphasis> are used to inhibit production of the thyroid hormone so that the body can maintain normal thyroid homeostasis. Antithyroid drugs act by inhibiting the synthesis of thyroid hormones or by inundating the thyroid gland with iodine to prevent thyroid hormone release. Antithyroid drugs are used when the thyroid hormone levels are elevated within the body.</para>
  <section id="sect-00009">
  <title>Thionamides</title>
  <para id="para-00017">Thionamides are compounds that effectively hinder the synthesis of thyroid hormones. These compounds are transported into the thyroid gland and act by inhibiting two critical processes: <emphasis effect="bold"><term id="term-00008">organification</term></emphasis> of iodine to tyrosine residues in <emphasis effect="bold"><term id="term-00009">thyroglobulin</term></emphasis> as well as coupling of <emphasis effect="bold"><term id="term-00010">iodotyrosines</term></emphasis>, leading to lower serum levels of thyroid hormones. The process of organification of iodine to tyrosine residues refers to the incorporation of iodine atoms into tyrosine amino acid molecules within the structure of thyroglobulin, a protein produced by the thyroid gland. This is an essential step in the synthesis of thyroid hormones. The coupling of iodotyrosines refers to the binding together of iodinated tyrosine molecules within the thyroglobulin to form the final thyroid hormones T3 and T4. Thionamides are used in the treatment of hyperthyroidism and Graves’ disease. Thionamides include methimazole and propylthiouracil.</para>
  <section id="sect-00010">
  <title>Methimazole</title>
  <para id="para-00018">Methimazole inhibits the synthesis of thyroid hormones and is indicated to treat hyperthyroidism. This medication is rapidly absorbed in the gastrointestinal tract and metabolized rapidly. It is excreted mainly in the urine but is excreted in breast milk and should be used cautiously with mothers who are breastfeeding. Careful dose titration is necessary to avoid overtreatment or undertreatment. When the client develops toxicity to methimazole, symptoms such as nausea, vomiting, epigastric distress, headache, fever, joint pain, pruritus, edema, and agranulocytosis may develop (Armstrong et al., 2022; DailyMed, <emphasis effect="italics">Methimazole,</emphasis> 2022; Shahid et al., 2022; Singh &amp; Correa, 2022).</para>
  </section>
  <section id="sect-00011">
  <title>Propylthiouracil</title>
  <para id="para-00019">Propylthiouracil inhibits the synthesis of thyroid hormones. This drug is readily absorbed and extensively metabolized; it is mainly excreted in the urine. Propylthiouracil is indicated for Graves’ disease with hyperthyroidism, multinodular <emphasis effect="bold"><term id="term-00011">goiter</term></emphasis>, and to ameliorate symptoms of hyperthyroidism before thyroidectomy or radioactive iodine therapy in clients who did not tolerate methimazole. It is contraindicated in clients with hypersensitivity and with liver failure. Adverse effects include hepatitis, jaundice, anemia, thrombocytopenia, nephritis, arthralgia, and paresthesia.</para>
  </section>
  </section>
  <section id="sect-00012">
  <title>Iodine</title>
  <para id="para-00020">The body naturally uses <emphasis effect="bold"><term id="term-00012">iodine</term></emphasis> for the formation of thyroid hormone. Iodine solutions cause the thyroid cells to become inundated with iodine, thereby decreasing thyroid hormone production. Iodine preparations are used to treat hyperthyroidism when thionamides are ineffective or for those clients who are not candidates for surgery.</para>
  <section id="sect-00013">
  <title>Potassium Iodide</title>
  <para id="para-00021">Potassium iodide prevents iodine from getting into the thyroid gland. As a medication, potassium iodine is used two separate ways: 1) to treat hyperthyroidism by inhibiting thyroid hormone secretion in very acute situations, and 2) to prevent the uptake of radioactive iodine in the event of a nuclear emergency. Additional use includes radioactive iodine to ablate a hyperactive thyroid gland. Adverse effects include skin rash, shortness of breath, wheezing, swelling, fever, and joint pain. It is contraindicated in those who have had an allergic reaction to iodine and those with nodular thyroid disease. <term class="no-emphasis" id="term-00013">ThyroShield</term> and <term class="no-emphasis" id="term-00014">Thyrosafe</term> are the only FDA-approved brands of potassium iodide.</para>
  <para id="para-00022"><link target-id="table-00003" document="m00410"/> lists common antithyroid drugs and typical routes and dosing for adult clients.</para>
  <table class="vertically-tight" id="table-00003">
  <tgroup cols="2">
  <colspec colnum="1" colname="c1" colwidth="1*"/>
  <colspec colnum="2" colname="c2" colwidth="2*"/>
  <thead>
  <row>
  <entry valign="top" align="center"><span class="blue-text"><emphasis effect="bold">Drug</emphasis></span></entry>
  <entry valign="top" align="center"><span class="blue-text"><emphasis effect="bold">Routes and Dosage Ranges</emphasis></span></entry>
  </row>
</thead>
  <tbody>
  <row>
  <entry valign="top" align="center"><term class="no-emphasis" id="term-00015">Methimazole</term> (<term class="no-emphasis" id="term-00016">Tapazole</term>)</entry>
  <entry valign="top" align="left"><emphasis effect="italics">Mild hyperthyroidism:</emphasis> 15 mg orally daily.<newline/>
  <emphasis effect="italics">Moderate hyperthyroidism:</emphasis> 30–40 mg orally daily.<newline/>
  <emphasis effect="italics">Severe hyperthyroidism:</emphasis> 60 mg orally daily, divided into 3 doses at 8-hour intervals.<newline/>
  <emphasis effect="italics">Maintenance dose:</emphasis> 5–15 mg orally daily.</entry>
  </row>
  <row>
  <entry valign="top" align="center"><term class="no-emphasis" id="term-00017">Propylthiouracil</term> (<term class="no-emphasis" id="term-00018">PTU</term>)</entry>
  <entry valign="top" align="left">300–400 mg orally daily; maintenance dose 100–150 mg orally daily.</entry>
  </row>
  <row>
  <entry valign="top" align="center"><term class="no-emphasis" id="term-00019">Potassium iodide</term> (<term class="no-emphasis" id="term-00020">Thyrosafe</term>)</entry>
  <entry valign="top" align="left">130 mg orally daily at 24-hour intervals.</entry>
  </row>
  </tbody>
  </tgroup>
  <caption><emphasis effect="bold">Drug Emphasis Table: Antithyroid Drugs</emphasis> (source: https://dailymed.nlm.nih.gov/dailymed/)</caption>
  </table>
  </section>
  </section>
  </section>
  <section id="sect-00014">
  <title>Adverse Effects and Contraindications</title>
  <para id="para-00023">Common adverse effects include the following:</para>
  <list list-type="bulleted" id="list-00005">
  <item>Rash or skin reactions—pruritis and hives</item>
  <item>Gastrointestinal symptoms—nausea and vomiting</item>
  <item>Liver toxicity—jaundice, dark urine, abdominal pain, fatigue</item>
  <item>Bone marrow suppression—decreased white blood cell, red blood cell, and platelet production leading to unexplained fever, sore throat, easy bruising, bleeding, and fatigue</item>
  <item>Hypothyroidism—increased fatigue, weight gain, cold intolerance, constipation</item>
  </list>
  <para id="para-00024">Contraindications include hypersensitivity to the drug or any of its components, severe liver disease or impairment, and with pregnancy or breastfeeding because the drugs can cross the placenta, be excreted in breast milk, and potentially affect the development of the fetus or infant.</para>
  <para id="para-00025"><link target-id="table-00004" document="m00410"/> is a drug prototype table for antithyroid drugs featuring methimazole. It lists drug class, mechanism of action, adult dosage, indications, therapeutic effects, drug and food interactions, adverse effects, and contraindications.</para>
  <table class="vertically-tight" id="table-00004">
  <tgroup cols="4">
  <colspec colnum="1" colname="c1" colwidth="1*"/>
  <colspec colnum="2" colname="c2" colwidth="1*"/>
  <colspec colnum="3" colname="c3" colwidth="1*"/>
  <colspec colnum="4" colname="c4" colwidth="1*"/>
  <tbody>
  <row>
  <entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Drug Class</emphasis></span><newline/>
  Antithyroid agent<newline count="2"/><span class="blue-text"><emphasis effect="bold">Mechanism of Action</emphasis></span><newline/>
  Inhibits the synthesis of thyroid hormones and thus is effective in the treatment of hyperthyroidism</entry>
  <entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Drug Dosage</emphasis></span><newline/>
  <emphasis effect="italics">Mild hyperthyroidism:</emphasis> 15 mg orally daily.<newline/>
  <emphasis effect="italics">Moderate hyperthyroidism:</emphasis> 30–40 mg orally daily.<newline/>
  <emphasis effect="italics">Severe hyperthyroidism:</emphasis> 60 mg orally daily, divided into 3 doses at 8-hour intervals.<newline/>
  <emphasis effect="italics">Maintenance dose:</emphasis> 5–15 mg orally daily.</entry>
  </row>
  <row>
  <entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Indications</emphasis></span><newline/>
  Hyperthyroidism<newline/>
  Ameliorating hyperthyroidism in preparation for subtotal thyroidectomy or radioactive iodine therapy<newline/>
  When thyroidectomy is contraindicated or not advisable<newline count="2"/><span class="blue-text"><emphasis effect="bold">Therapeutic Effects</emphasis></span><newline/>
  Lowers thyroid hormone levels <newline/>
  Relieves/reduces manifestations of hyperthyroidism</entry>
  <entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Drug Interactions</emphasis></span><newline/>
  Anticoagulants<newline/>
  Beta-adrenergic blockers<newline/>
  Digitalis glycosides<newline/>
  Theophylline<newline count="2"/><span class="blue-text"><emphasis effect="bold">Food Interactions</emphasis></span><newline/>
  No significant interactions</entry>
  </row>
  <row>
  <entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Adverse Effects</emphasis></span><newline/>
  Agranulocytosis<newline/>
  Thrombocytopenia<newline/>
  Aplastic anemia<newline/>
  Fever<newline/>
  Insulin autoimmune syndrome (low blood glucose levels)<newline/>
  Jaundice<newline/>
  Urticaria<newline/>
  Epigastric distress<newline/>
  Arthralgia</entry>
  <entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Contraindications</emphasis></span><newline/>
  Hypersensitivity<newline/>
  Pregnancy and breastfeeding<newline count="2"/>Caution:<newline/>
  Monitor closely for agranulocytosis and hepatotoxicity</entry>
  </row>
  </tbody>
  </tgroup>
  <caption><emphasis effect="bold">Drug Prototype Table: Methimazole</emphasis> (source: https://dailymed.nlm.nih.gov/dailymed/)</caption>
  </table>
  </section>
  <section id="sect-00015">
  <title>Nursing Implications for Antithyroid Drugs</title>
  <para id="para-00026">The nurse should do the following for clients who are taking antithyroid drugs:</para>
  <list list-type="bulleted" id="list-00006">
  <item>Monitor complete blood cell count and coagulation studies, liver studies, and thyroid levels and report abnormalities to the health care provider.</item>
  <item>Check with the health care provider before administering antithyroid drugs if the client is currently taking anticoagulants, beta-adrenergic blockers and digitalis glycosides, or theophylline, which stimulates the central nervous system and when taken with antithyroid drugs can impact mood, behavior, cognition, and sleep patterns.</item>
  <item>Provide client teaching regarding the drug and when to call the health care provider. See below for additional client teaching guidelines.</item>
  </list>
  <note class="client-teaching" id="note-00004">
  <para id="para-00027"><emphasis effect="bold">The client taking an antithyroid drug should:</emphasis></para>
  <list list-type="bulleted" id="list-00007">
  <item>Take the drug exactly as prescribed by the health care provider.</item>
  <item>Report sore throat, skin eruptions, fever, headache, or general malaise to the health care provider because these may be symptoms of a severe reaction.</item>
  <item>Monitor weight weekly and report a weight gain of 3 pounds in 24 hours or 5 pounds in a week to the health care provider.</item>
  <item>Notify the health care provider if they are pregnant or plan to become pregnant or if they are breastfeeding.</item>
  <item>Store out of reach of children and away from heat, moisture, and light.</item>
  </list>
  <para id="para-00028"><emphasis effect="bold">The client taking an antithyroid drug <emphasis effect="italics">should not:</emphasis></emphasis></para>
  <list list-type="bulleted" id="list-00008">
  <item>Eat dietary sources of iodine (iodized salt, shellfish) without speaking with the health care provider first.</item>
  </list>
  </note>
  <note class="black-box" id="note-00005">
  <para id="para-00029"><emphasis effect="bold">Propylthiouracil</emphasis></para>
  <para id="para-00030">Severe liver injury and acute liver failure have been reported in clients treated with propylthiouracil.</para>
  </note>
  <note class="single-casestudy" id="note-00006">
  <para id="para-00031">Read the following clinical scenario to answer the questions that follow.</para>
<para id="para-00034">Ellis Dominico is a 40-year-old client who visits their primary health care provider’s office for a checkup. Ellis reports fatigue and decreased energy, constipation, and having an intolerance to cold temperatures.<newline count="2"/><emphasis effect="bold">History</emphasis><newline count="2"/>Hyperthyroidism (diagnosed 6 months ago)<newline count="2"/><emphasis effect="bold">Current Medications</emphasis><newline count="2"/>Methimazole, 15 mg orally daily</para>
  <table class="vertically-tight full-width" id="table-00005">
  <tgroup cols="3">
  <colspec colnum="1" colname="c1" colwidth="1*"/>
  <colspec colnum="2" colname="c2" colwidth="1*"/>
  <colspec colnum="3" colname="c3" colwidth="3*"/>
 <thead>
  <row>
<entry valign="top" align="center" namest="c1" nameend="c2"><span class="blue-text"><emphasis effect="bold">Vital Signs</emphasis></span></entry>
<entry valign="top" align="center"><emphasis effect="bold"><span class="blue-text">Physical Examination</span></emphasis></entry>
</row>
</thead>
<tbody>
  <row>
  <entry valign="top" align="left"><emphasis effect="italics">Temperature:</emphasis></entry>
<entry valign="top" align="left">98.3°F</entry>
  <entry valign="top" align="left" morerows="6"><list list-type="bulleted" id="list-00009"><item><emphasis effect="italics">Head, eyes, ears, nose, throat (HEENT):</emphasis> Within normal limits</item>
<item><emphasis effect="italics">Cardiovascular:</emphasis> No jugular vein distention; no peripheral edema noted; S1, S2 auscultated, rhythm regular</item>
<item><emphasis effect="italics">Respiratory:</emphasis> Lungs clear to auscultation bilaterally</item>
<item><emphasis effect="italics">GI:</emphasis> Abdomen firm, nontender, slightly distended</item>
<item><emphasis effect="italics">GU:</emphasis> Client reports urinary output unchanged from their baseline</item>
<item><emphasis effect="italics">Neurological:</emphasis> Lethargy and slow speech noted; no other neurological deficits noted</item>
<item><emphasis effect="italics">Integumentary:</emphasis> No wounds noted; skin appropriate for age</item></list></entry>
</row>
<row>
<entry valign="top" align="left"><emphasis effect="italics">Blood pressure</emphasis>:</entry>
<entry valign="top" align="left">96/58 mm Hg</entry>
</row>
<row>
<entry valign="top" align="left"><emphasis effect="italics">Heart rate:</emphasis></entry>
<entry valign="top" align="left">58 beats/min</entry>
</row>
<row>
<entry valign="top" align="left"><emphasis effect="italics">Respiratory rate</emphasis>:</entry>
<entry valign="top" align="left">18 breaths/min</entry>
</row>
<row>
<entry valign="top" align="left"><emphasis effect="italics">Oxygen saturation</emphasis>:</entry>
<entry valign="top" align="left">95% on room air</entry>
</row>
<row>
<entry valign="top" align="left"><emphasis effect="italics">Height</emphasis>:</entry>
<entry valign="top" align="left">5’6”</entry>
</row>
<row>
<entry valign="top" align="left"><emphasis effect="italics">Weight</emphasis>:</entry>
<entry valign="top" align="left">211 pounds (10 pounds heavier than weight 3 months ago)</entry>
</row>
  </tbody>
  </tgroup>
  </table>
  <exercise id="exer-00001"><problem id="prob-00001"><para id="para-00032"><link class="os-embed" url="#exercise/PHAR_Ch27_Sec01_UCSQ1"/></para></problem></exercise>
  <exercise id="exer-00002"><problem id="prob-00002"><para id="para-00033"><link class="os-embed" url="#exercise/PHAR_Ch27_Sec01_UCSQ2"/></para></problem></exercise>
  </note>
  </section>
  </content>
  <glossary>
  <definition id="def-00001"><term>antithyroid drugs</term> <meaning>inhibit the thyroid hormone so that the body can maintain normal thyroid homeostasis</meaning></definition>
  <definition id="def-00002"><term>goiter</term> <meaning>an abnormal enlargement of the thyroid gland</meaning></definition>
  <definition id="def-00003"><term>iodine</term> <meaning>a mineral that the body needs to produce thyroid hormones</meaning></definition>
  <definition id="def-00004"><term>iodotyrosine</term> <meaning>an iodo-derivative of tyrosine that acts as an intermediary in the biosynthesis of thyroid hormone</meaning></definition>
  <definition id="def-00005"><term>organification</term> <meaning>the biochemical process that takes place in the thyroid gland, involving the incorporation of iodine into thyroglobulin for the production of thyroid hormone</meaning></definition>
  <definition id="def-00006"><term>thyroglobulin</term> <meaning>a protein present in the thyroid gland from which thyroid hormones are synthesized</meaning></definition>
  <definition id="def-00007"><term>thyroid drugs</term> <meaning>drugs that replace the thyroid hormone so that the body can maintain its normal function</meaning></definition>
  </glossary>
  </document>